Many natural bacterial components as adjuvants can activate the host immune system, but the excessive toxicity and structure-identification challenge limit their applications and structure-activity relationship studies. Herein, we report the role of a series of chemically synthesized mannose-capped arabinomannan motifs from Mycobacterium tuberculosis cell wall, including 18-mer, 19-mer, 27-mer, and 101-mer in regulating host immunity. As an influenza vaccine adjuvant, 101-mer induced significantly enhanced anti-influenza antibody response and immune protection compared with other arabinomannan motifs. 101-mer elicited robust immunoenhancement while exhibiting a favorable tolerability profile, as it did not trigger any observable physiological toxicity or inflammatory reactions in various organs. Mechanistically, we found 101-mer may serve as a Dectin-2 agonist to activate host immunity through Syk/NF-kappa B signaling. This study provided a new oligosaccharide candidate that can satisfy the required "efficacy-safety" balance for clinical adjuvant development.
[1]Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China.
[2]Kunming Med Univ, Kunming, Yunnan, Peoples R China.
[3]Univ Chinese Acad Sci, Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Nat Med, Kunming, Yunnan, Peoples R China.
[4]State Key Lab Resp Hlth & Multimorbid, Beijing, Peoples R China.
[5]Peking Union Med Coll, Key Lab Pathogen Infect Prevent & Control, Minist Educ, Beijing, Peoples R China.
(8.0+极速模式)